Answer
Exblifep should be used during pregnancy only when clearly indicated and when the benefit to the mother outweighs the risk to the child, with no human pregnancy data available and animal studies showing reproductive toxicity at clinically relevant enmetazobactam exposure but no signs of teratogenicity.
Sources for this answer
- EXBLIFEP 2 g/0.5 g powder for concentrate for solution for infusionADVANZ Pharma · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked